Literature DB >> 26629460

Case of hemophagocytic lymphohistiocytosis with leishmaniasis.

Harish Chandra1, Smita Chandra1.   

Abstract

Entities:  

Year:  2015        PMID: 26629460      PMCID: PMC4557156          DOI: 10.4103/2229-5070.162534

Source DB:  PubMed          Journal:  Trop Parasitol        ISSN: 2229-5070


× No keyword cloud information.
Sir, Hemophagocytosis is although a common phenomenon observed in bone marrow but at times it is overlooked. It is essential to distinguish whether the hemophagocytosis present in the marrow is only an isolated finding or is associated with hemophagocytic lymphohistiocytosis (HLH) syndrome. HLH requires certain clinical, biochemical and genetic criteria, which are to be fulfilled for its diagnosis.[12] The differentiation of hemophagocytosis triggered due to infection or secondary HLH associated with infection is important as HLH is life threatening condition and only the pathogen directed therapy is usually not sufficient to control severe hyper-inflammation in HLH.[3] The association of HLH with leishmaniasis has been rarely described in the literature, and present report describes it. A 25-year-old male presented with fever and abdominal distension for last 6 weeks. Ultrasonography of the upper abdomen showed gross spleenomegaly and hepatomegaly. Laboratory investigations revealed pancytopenia with total leukocyte count of 0.84 × 109/L, hemoglobin of 69.6 g/L, total red blood cell count of 2.3 × 1012/L and platelet count of 67 × 109/L. Peripheral blood smear examination revealed predominantly normocytic normochromic erythrocytes with leucopenia and marked neutropenia. The serum aspartate aminotransferase level (50 IU/L) and serum alkaline phosphatase was elevated (234 IU/L) with hyponatremia (131.7 mmol/L). Serum ferritin (750 μg/L) and triglycerides levels (350 mg/dl) were also increased with hypoalbuminemia (1.4 g/dl). The patient was nonreactive for hepatitis B surface antigen and hepatitis C virus antibody. In view of pancytopenia, the patient was subjected to bone marrow examination. Jenner Giemsa stain of bone marrow aspirate smears showed predominantly normoblastic maturation with adequate and functional megakaryocytes. The smears also revealed Leishmania donovani (LD) amastigote forms (LD bodies) along with the phenomenon of hemophagocytosis demonstrating reactive histiocytes containing phagocytosed LD bodies along with phagocytosed leukocytes [Figure 1]. Based on these findings the case was diagnosed as leishmaniasis with HLH syndrome. The patient responded adequately to amphotericin and was later discharged.
Figure 1

Bone marrow aspirate showing phenomenon of hemophagocytosis demonstrating reactive histiocytes containing phagocytosed leukocyte and bodies (Jenner Giemsa; ×1000)

Bone marrow aspirate showing phenomenon of hemophagocytosis demonstrating reactive histiocytes containing phagocytosed leukocyte and bodies (Jenner Giemsa; ×1000) Hemophagocytic lymphohistiocytosis is described as highly stimulated and ineffective immune response that may be familial or acquired and is considered as life-threatening condition.[3] Hypersecretion of pro-inflammatory cytokines such as interferon gamma, tumor necrosis factor alpha, and CD8 T-cells are said to play a crucial role in the pathogenesis of HLH.[34] HLH associated with leishmaniasis is rarely reported in the literature and at times the diagnosis of this association may be challenging.[5] It is necessary to distinguish between leishmaniasis showing hemophagocytosis on bone marrow and a case of secondary HLH with leishmaniasis. Bone marrow examination, which may be at times repeated along with relevant biochemical and laboratory examination, is essential for a definite diagnosis. The early recognition of HLH with leishmaniasis followed by prompt treatment is necessary to avoid poor prognosis of such cases.
  5 in total

1.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

2.  Hemophagocytic lymphohistiocytosis in imported pediatric visceral leishmaniasis in a nonendemic area.

Authors:  Sebastian F N Bode; Christian Bogdan; Karin Beutel; Wolfgang Behnisch; Jeanette Greiner; Stephan Henning; Norbert Jorch; Martin Jankofsky; Marcus Jakob; Irene Schmid; Norbert Veelken; Thomas Vraetz; Gritta Janka; Stephan Ehl; Kai Lehmberg
Journal:  J Pediatr       Date:  2014-05-03       Impact factor: 4.406

Review 3.  Hemophagocytic lymphohistiocytosis: pathogenesis and treatment.

Authors:  Gritta E Janka; Kai Lehmberg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2013

4.  An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.

Authors:  Michael B Jordan; David Hildeman; John Kappler; Philippa Marrack
Journal:  Blood       Date:  2004-04-06       Impact factor: 22.113

Review 5.  Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis.

Authors:  Sebastian Fn Bode; Kai Lehmberg; Andrea Maul-Pavicic; Thomas Vraetz; Gritta Janka; Udo Zur Stadt; Stephan Ehl
Journal:  Arthritis Res Ther       Date:  2012-06-08       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.